Mary C. Spellman, MD, FAAD
SESSIONS
S034 Late-Breaking Research: Session 2
Mar 28, 2026
•
1:00 PM - 4:00 PM
•
Bellco Theatre
DISCLOSURES
Azitra Inc – Consultant (1099 relationship)(Other Financial Benefit); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Other Financial Benefit); Phio Pharmaceuticals Inc – Consultant (1099 relationship)(Other Financial Benefit); Rubedo Life Sciences – Consultant (1099 relationship)(Other Financial Benefit);